Early Trial Data Released for Potential Mycosis Fungoides Treatment

According to a story from biotech-finances.com, the biopharmaceutical company miRagen Therapeutics, Inc., recently announced the release of data from a Phase 1 clinical trial of miR-155 inhibitor cobomarsen as a…

Continue Reading Early Trial Data Released for Potential Mycosis Fungoides Treatment
Close Menu